| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | 30.4 |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | n/a | (4.07) | (1.70)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | n/a | (9.33) | (4.40)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (5.99) | (2.80)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | 4.24 | (1.70)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | (0.56) | (0.29)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Commissioning of Second UK Inserma Unit | 09-Mar-2026 | 07:00 | RNS |
| ISSUE OF SHARES FOLLOWING VESTING OF RSUs | 18-Feb-2026 | 07:00 | RNS |
| Submission Draft Registration Statement | 16-Feb-2026 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 47.50p |
| Change Today | -1.30p |
| % Change | -2.66 % |
| 52 Week High | 69.00 |
| 52 Week Low | 9.42 |
| Volume | 444,461 |
| Shares Issued | 349.23m |
| Market Cap | £165.88m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:29 | 35,994 @ 47.25p |
| 16:21 | 35,000 @ 47.33p |
| 16:23 | 5,000 @ 47.78p |
| 16:17 | 1,756 @ 47.80p |
| 16:10 | 10,000 @ 47.87p |
| CEO | William (Will) Drummond Dawes |
| CFO | Robert Sewell |
You are here: research